Road Runner Research, Ltd | San Antonio, TX

Research site
4374 Lockhill Selma Road, Suite 108, San Antonio, Texas, United States of America

Site insights

Top conditions

Top treatments

Ecopipam Hydrochloride

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

10 of 10 total trials

A Study of Eptinezumab in Pediatric Participants With Episodic Migraine (PROSPECT-1)

The main goal of this trial is to learn whether eptinezumab helps reduce the number of days with episodic migraine in pediatric participants.

Episodic Migraine
Drug: Placebo
Drug: Eptinezumab
Locations recently updated

The purpose of this study is to determine whether BHV-7000 is effective in the treatment of refractory focal epilepsy.

Focal Epilepsy
Drug: BHV-7000
Drug: Placebo

Researchers are looking for a better way to treat women who have sleep disturbances associated with menopause.Menopause is part of a natural aging pr...

Sleep Disturbances Associated With Menopause
Other: Placebo
Drug: Elinzanetant
Locations recently updated

To find out if eptinezumab is better than placebo (normal saline solution) in lowering the number of days with migraine in young people ages 12 to 17...

Chronic Migraine in Children
Drug: Placebo
Drug: Eptinezumab

The main goal of the study is to assess the long-term safety of eptinezumab on children and adolescents ages 6 to 17 with chronic or episodic migrain...

Drug: Eptinezumab

This study aims to evaluate the safety and tolerability of clesrovimab compared to palivizumab as assessed by the proportion of participants experien...

Active, not recruiting
RSV Infection
Biological: Placebo
Biological: Clesrovimab

This Phase 3 multicenter study evaluates the maintenance of efficacy, safety and tolerability of ecopipam tablets in children, adolescents and adults...

Tourette Disorder
Drug: Ecopipam Hydrochloride

ML-004-002 is a multi-center, randomized, double-blind, parallel-group, placebo-controlled study that will enroll approximately 150 adolescent and ad...

Autism Spectrum Disorder
Drug: ML-004 Placebo
Drug: ML-004 (IR)/(ER) tablet

ML-004-003 is a multi-center, open-label extension study that will enroll approximately 120 adolescent and adult subjects with ASD that have complete...

Autism Spectrum Disorder
Drug: ML-004 (IR)/(ER) tablet

Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache, often associated with nausea...

Drug: Placebo-Matching Ubrogepant
Drug: Ubrogepant

Trial sponsors

Lundbeck logo
AbbVie logo
Bayer logo
Biohaven logo
Merck Sharp & Dohme (MSD) logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems